Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4869807
Max Phase: Preclinical
Molecular Formula: C45H64N3O12P
Molecular Weight: 869.99
Molecule Type: Unknown
Associated Items:
ID: ALA4869807
Max Phase: Preclinical
Molecular Formula: C45H64N3O12P
Molecular Weight: 869.99
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOP(=O)(/C=C/C(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3)NC(=O)OCc1ccccc1)c1ccccc1)OCC
Standard InChI: InChI=1S/C45H64N3O12P/c1-8-55-61(52,56-9-2)25-23-36(33-18-14-11-15-19-33)46-39(49)37(26-29(3)4)47-40(50)38(48-43(51)54-27-32-16-12-10-13-17-32)28-53-41-31(6)35-21-20-30(5)34-22-24-44(7)58-42(57-41)45(34,35)60-59-44/h10-19,23,25,29-31,34-38,41-42H,8-9,20-22,24,26-28H2,1-7H3,(H,46,49)(H,47,50)(H,48,51)/b25-23+/t30-,31-,34+,35+,36?,37+,38+,41+,42-,44-,45-/m1/s1
Standard InChI Key: NICUQVPQDBOIPE-PMSYGICFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 869.99 | Molecular Weight (Monoisotopic): 869.4228 | AlogP: 7.67 | #Rotatable Bonds: 19 |
Polar Surface Area: 178.21 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.05 | CX Basic pKa: | CX LogP: 7.14 | CX LogD: 7.14 |
Aromatic Rings: 2 | Heavy Atoms: 61 | QED Weighted: 0.09 | Np Likeness Score: 1.23 |
1. Aratikatla EK, Kalamuddin M, Rana KC, Datta G, Asad M, Sundararaman S, Malhotra P, Mohmmed A, Bhattacharya AK.. (2021) Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials., 220 [PMID:33901900] [10.1016/j.ejmech.2021.113454] |
Source(1):